diaprel mr 60 mg
anpharm przedsiebiorstwo farmaceutyczne s.a., poľsko - gliklazid - 18 - antidiabetica (vrÁtane inzulÍnu)
gluctam mr 60 mg
les laboratoires servier - gliklazid - 18 - antidiabetica (vrÁtane inzulÍnu)
asolfena 5 mg
krka, d.d., novo mesto, slovinsko - solifenacín - 73 - spasmolytica
asolfena 10 mg
krka, d.d., novo mesto, slovinsko - solifenacín - 73 - spasmolytica
gliclada 60 mg
krka, d.d., novo mesto, slovinsko - gliklazid - 18 - antidiabetica (vrÁtane inzulÍnu)
verzenios
eli lilly nederland b.v. - abemaciclib - neoplazmy prsníkov - antineoplastické činidlá - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
humulin n (nph) cartridge
eli lilly Čr, s.r.o., Česká republika - Ľudský inzulín - 18 - antidiabetica (vrÁtane inzulÍnu)
gliklazid sandoz 60 mg tablety s riadeným uvoľňovaním
sandoz pharmaceuticals d.d., slovinsko - gliklazid - 18 - antidiabetica (vrÁtane inzulÍnu)
levosert
gedeon richter plc., maďarsko - vnútromaternicové teliesko s progestínom - 17 - anticoncipientia
prestilol 5 mg/5 mg
anpharm przedsiebiorstwo farmaceutyczne s.a., poľsko - perindopril a bisoprolol - 58 - hypotensiva